AHK-Cu 100mg
€ 69,00
AHK-Cu 100 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms 99.8 % purity, assay content verified at 105.8 mg and endotoxin levels below 0.001 EU/mg.
Supplied as a 100 mg lyophilized peptide with full COA traceability.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
For research use only — not for human or veterinary use.
Analytical Verification (COA)
Each batch of AHK-Cu supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.
Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.
Batch: GF-AHK100-B241
Key analytical results include:
- Assay Content: 105.8 mg
- Identification – Retention Time: 0.993
- Identification – Spectrum: 999
- Purity: greater than 99.8 percent
- Bacterial Endotoxins: below 0.001 EU per mg
- Total Aerobic Microbial Count: not detected
- Total Yeast and Mold Count: not detected
Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.
These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.
Product Overview
AHK-Cu is a copper-binding peptide complex studied in controlled laboratory environments focused on peptide signalling pathways and molecular regulatory systems.
The compound is commonly investigated in biochemical research for its interaction with peptide-mediated signalling and copper-associated biological processes.
This preparation contains 100 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves compound stability and allows researchers to reconstitute it for controlled in vitro experimentation.
Due to its defined molecular structure and stable analytical profile, AHK-Cu is frequently referenced in peptide and biochemical research models.
Compound Overview
AHK-Cu is a synthetic peptide complex associated with copper-binding activity, studied in biochemical research for its interaction with signalling pathways.
Within experimental models, it is commonly investigated for its role in peptide-mediated cellular processes and molecular signalling mechanisms.
Because of its defined molecular structure and metal-binding properties, the compound is frequently used in laboratory studies examining peptide interactions and regulatory systems.
Historical Background and Scientific Context
Scientific interest in copper-binding peptides has grown with advancements in molecular biology and peptide research.
Peptide-metal complexes such as AHK-Cu have been explored in controlled laboratory environments to better understand signalling pathways and cellular regulation mechanisms.
This has contributed to broader research into peptide-based systems and molecular signalling processes.
Mechanistic Focus in Research
Within experimental laboratory settings, AHK-Cu is commonly studied in relation to peptide-mediated signalling and copper-associated regulatory pathways.
Research investigations commonly explore the compound in experimental models examining:
- Peptide signalling pathways
- Copper-associated molecular interactions
- Cellular regulatory mechanisms
- Intracellular signalling systems
- Comparative peptide research
- Molecular pathway analysis
- Regulatory interaction modelling
These experimental models allow scientists to investigate molecular mechanisms involved in peptide-mediated signalling and regulatory processes.
Research Applications
In controlled research environments, AHK-Cu may be utilised in experimental models designed to explore peptide signalling systems and molecular interactions.
Examples of research applications include:
- Peptide signalling pathway investigation
- Molecular interaction studies
- Intracellular signalling modelling
- Comparative peptide analysis
- Metal-binding peptide research
- Regulatory pathway analysis
- Controlled in vitro studies
Grail Formula Quality
Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.
Each batch undergoes independent analytical testing to verify:
- Compound identity
- Assay accuracy
- Purity confirmation
- Microbial safety
- Endotoxin levels
- Heavy metal screening
- Full batch traceability
All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.
Research Use Limitation
- Used solely for in vitro experiments
- Not permitted for clinical trials involving humans
- Not permitted for human or veterinary administration
- Not permitted for investigational human use
- Independently analysed by Liquilabs s.r.o. Czechia
- 99.8 % purity confirmed by COA
- Assay content verified at 105.8 mg
- Endotoxin level below 0.001 EU/mg
- No detectable heavy metals or microbial contamination
- Copper peptide complex for controlled laboratory research
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.




